Fundraising Fox

ImmuneSensor Therapeutics

Dallas, US · Founded 2019 · Delaware corporation

ImmuneSensor Therapeutics is a clinical-stage biotechnology company developing orally available small molecule cGAS inhibitors that target the cGAS-STING innate immune pathway to treat inflammatory and autoimmune diseases. Founded on research from UT Southwestern Medical Center, it advances a pipeline of drug candidates for immune-related conditions.

BiotechDeep TechHealthtech

Founders & leadership

ImmuneSensor Therapeutics was founded in 2019 by Zhijian "James" Chen and Jet Li.

Z"
Zhijian "James" Chen
JL
Jet LiBoard Chairman and Co-Founder
TW
Thomas W. Dubensky, Jr., Ph.D.President and Chief Executive Officer
L'
Lijun 'Josh' Sun, Ph.D.VP, Research & Development
TMTeresa Mooneyham
Teresa MooneyhamVP, Clinical Operations & Head of Project Management
BL
Betty LawrenceVP, Toxicology and Regulatory
QL
Qingsong LiNamed on SEC filing
ZH
Zhi HongNamed on SEC filing
EW
Ernest WongNamed on SEC filing
NZ
Ning ZhangNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 1 round · 2022

▶$10MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Qingsong LiExecutive Officer, Director
  • Zhi HongDirector
  • Ernest WongExecutive Officer, Director
  • Ning ZhangDirector
Offering amount
$20M
Amount sold
$10M
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Oup15 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.

Companies competing with ImmuneSensor Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does ImmuneSensor Therapeutics do?
ImmuneSensor Therapeutics is a clinical-stage biotechnology company developing orally available small molecule cGAS inhibitors that target the cGAS-STING innate immune pathway to treat inflammatory and autoimmune diseases. Founded on research from UT Southwestern Medical Center, it advances a pipeline of drug candidates for immune-related conditions.
Who founded ImmuneSensor Therapeutics?
ImmuneSensor Therapeutics was founded by Zhijian "James" Chen, Jet Li in 2019.
How much funding has ImmuneSensor Therapeutics raised?
ImmuneSensor Therapeutics has disclosed $10M raised across 1 round.
Where is ImmuneSensor Therapeutics headquartered?
ImmuneSensor Therapeutics is headquartered in Dallas, US.